522 related articles for article (PubMed ID: 17923599)
1. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
Davila JA; El-Serag HB
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
Shea KA; Fleming LE; Wilkinson JD; Wohler-Torres B; McKinnon JA
Cancer; 2001 Mar; 91(5):1046-51. PubMed ID: 11251958
[TBL] [Abstract][Full Text] [Related]
5. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.
Kubo A; Corley DA
Am J Gastroenterol; 2004 Apr; 99(4):582-8. PubMed ID: 15089886
[TBL] [Abstract][Full Text] [Related]
6. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003.
Goodman MT; Hernandez BY; Shvetsov YB
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1833-9. PubMed ID: 17855702
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of cancer among Hispanics in the United States.
Trapido EJ; Burciaga Valdez R; Obeso JL; Strickman-Stein N; Rotger A; Pérez-Stable EJ
J Natl Cancer Inst Monogr; 1995; (18):17-28. PubMed ID: 8562218
[TBL] [Abstract][Full Text] [Related]
8. All-cause mortality among Hispanics in the United States: exploring heterogeneity by nativity status, country of origin, and race in the National Health Interview Survey-linked Mortality Files.
Borrell LN; Crawford ND
Ann Epidemiol; 2009 May; 19(5):336-43. PubMed ID: 19230710
[TBL] [Abstract][Full Text] [Related]
9. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
10. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma.
O'Malley CD; Prehn AW; Shema SJ; Glaser SL
Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370
[TBL] [Abstract][Full Text] [Related]
12. Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States).
Pinsky PF
Cancer Causes Control; 2006 Oct; 17(8):1017-24. PubMed ID: 16933052
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
14. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
Rouhani P; Fletcher CD; Devesa SS; Toro JR
Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
[TBL] [Abstract][Full Text] [Related]
16. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas.
Hu DN; Yu G; McCormick SA; Finger PT
Am J Ophthalmol; 2008 Mar; 145(3):418-423. PubMed ID: 18191091
[TBL] [Abstract][Full Text] [Related]
17. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.
El-Serag HB; Mason AC; Key C
Hepatology; 2001 Jan; 33(1):62-5. PubMed ID: 11124821
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
19. Validation of ethnicity in cancer data: which Hispanics are we misclassifying?
Pinheiro PS; Sherman R; Fleming LE; Gomez-Marin O; Huang Y; Lee DJ; Penedo FJ
J Registry Manag; 2009; 36(2):42-6. PubMed ID: 19694116
[TBL] [Abstract][Full Text] [Related]
20. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
